Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Plasma Exchange | 6 | 2021 | 763 | 2.69 | Why? |
| Brain Chemistry | 1 | 2020 | 49 | 0.85 | Why? |
| Coronary Vessel Anomalies | 1 | 2021 | 87 | 0.81 | Why? |
| Dissent and Disputes | 1 | 2021 | 117 | 0.78 | Why? |
| Subcutaneous Emphysema | 2 | 2020 | 166 | 0.73 | Why? |
| Ultrasonics | 1 | 2017 | 41 | 0.69 | Why? |
| Metapneumovirus | 1 | 2020 | 465 | 0.68 | Why? |
| Cardiotonic Agents | 1 | 2020 | 418 | 0.67 | Why? |
| Paramyxoviridae Infections | 1 | 2020 | 364 | 0.66 | Why? |
| Ossification, Heterotopic | 1 | 2017 | 60 | 0.66 | Why? |
| Ultrasonography | 7 | 2020 | 4409 | 0.61 | Why? |
| Pediatric Emergency Medicine | 1 | 2017 | 120 | 0.60 | Why? |
| Transportation of Patients | 1 | 2020 | 494 | 0.56 | Why? |
| Ultrasonography, Doppler | 1 | 2017 | 406 | 0.54 | Why? |
| Lung Injury | 2 | 2020 | 919 | 0.54 | Why? |
| Air Travel | 1 | 2021 | 585 | 0.53 | Why? |
| Tissue Plasminogen Activator | 1 | 2020 | 778 | 0.53 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2020 | 453 | 0.53 | Why? |
| Endothelium, Vascular | 2 | 2020 | 1751 | 0.52 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.52 | Why? |
| Mediastinal Emphysema | 1 | 2020 | 519 | 0.51 | Why? |
| Sinusitis | 1 | 2020 | 649 | 0.48 | Why? |
| Vascular Diseases | 1 | 2021 | 846 | 0.47 | Why? |
| Pneumothorax | 1 | 2020 | 758 | 0.46 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.44 | Why? |
| Point-of-Care Testing | 3 | 2020 | 2782 | 0.44 | Why? |
| Microsurgery | 1 | 2013 | 166 | 0.43 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.37 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.36 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.36 | Why? |
| Lower Extremity | 1 | 2013 | 593 | 0.35 | Why? |
| Critical Illness | 7 | 2021 | 17281 | 0.34 | Why? |
| Cough | 1 | 2021 | 4891 | 0.33 | Why? |
| Carotid Artery, Common | 1 | 2006 | 49 | 0.33 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.32 | Why? |
| Point-of-Care Systems | 3 | 2020 | 2955 | 0.30 | Why? |
| Intensive Care Units | 9 | 2021 | 29594 | 0.29 | Why? |
| Diagnostic Imaging | 1 | 2013 | 1044 | 0.28 | Why? |
| Pulmonary Embolism | 2 | 2020 | 4775 | 0.27 | Why? |
| Cytokines | 3 | 2020 | 15010 | 0.26 | Why? |
| Androgens | 1 | 2006 | 267 | 0.26 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.26 | Why? |
| Pilot Projects | 3 | 2020 | 5182 | 0.25 | Why? |
| Reconstructive Surgical Procedures | 1 | 2013 | 860 | 0.25 | Why? |
| Brain | 1 | 2020 | 5133 | 0.25 | Why? |
| Testosterone | 1 | 2006 | 596 | 0.22 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.22 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.21 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.21 | Why? |
| Head Protective Devices | 1 | 2020 | 163 | 0.20 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.17 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Bilirubin | 1 | 2020 | 503 | 0.17 | Why? |
| Critical Care | 5 | 2021 | 14081 | 0.16 | Why? |
| Intracranial Pressure | 1 | 2017 | 90 | 0.16 | Why? |
| Humans | 30 | 2021 | 930598 | 0.16 | Why? |
| Optic Nerve | 1 | 2017 | 123 | 0.16 | Why? |
| Respiration, Artificial | 5 | 2020 | 22116 | 0.15 | Why? |
| Intracranial Hypertension | 1 | 2017 | 111 | 0.15 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.14 | Why? |
| Feasibility Studies | 2 | 2020 | 3467 | 0.13 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.12 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2013 | 107 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.12 | Why? |
| Angiography | 1 | 2013 | 301 | 0.11 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.11 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.11 | Why? |
| Continuous Positive Airway Pressure | 1 | 2020 | 1187 | 0.11 | Why? |
| Male | 15 | 2021 | 367725 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Kidney Failure, Chronic | 1 | 2006 | 3222 | 0.10 | Why? |
| Saudi Arabia | 2 | 2020 | 4423 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.10 | Why? |
| Elasticity | 1 | 2008 | 70 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 2 | 2008 | 993 | 0.10 | Why? |
| Fellowships and Scholarships | 1 | 2017 | 931 | 0.09 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
| Peripheral Nerves | 1 | 2008 | 74 | 0.09 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.09 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.09 | Why? |
| Imaging, Three-Dimensional | 1 | 2013 | 680 | 0.09 | Why? |
| Echocardiography | 2 | 2020 | 3661 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.08 | Why? |
| Adult | 10 | 2021 | 244371 | 0.08 | Why? |
| Brachial Artery | 1 | 2006 | 107 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Cardiomyopathy, Dilated | 1 | 2008 | 251 | 0.07 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Nerve Block | 1 | 2008 | 183 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Vasodilation | 1 | 2006 | 258 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.06 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.06 | Why? |
| Oxygen Consumption | 2 | 2020 | 711 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Animals | 2 | 2020 | 78931 | 0.05 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Atherosclerosis | 1 | 2006 | 768 | 0.05 | Why? |
| Lactic Acid | 1 | 2020 | 393 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Causality | 1 | 2020 | 857 | 0.04 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Ultrasonography, Doppler, Pulsed | 1 | 2008 | 5 | 0.02 | Why? |
| Renal Dialysis | 1 | 2006 | 4358 | 0.02 | Why? |
| Subcutaneous Tissue | 1 | 2008 | 18 | 0.02 | Why? |
| Systole | 1 | 2008 | 252 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Observer Variation | 1 | 2008 | 622 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Edema | 1 | 2008 | 333 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Exercise Test | 1 | 2008 | 911 | 0.01 | Why? |
| Respiratory Function Tests | 1 | 2008 | 1755 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Hemodynamics | 1 | 2008 | 1562 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Case-Control Studies | 1 | 2008 | 17671 | 0.01 | Why? |
Karakitsos's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_